Wordt geladen...
Novel Biomarkers for Personalized Cancer Immunotherapy
Cancer immunotherapy has emerged as a novel and effective treatment strategy for several types of cancer. Immune checkpoint inhibitors (ICIs) have recently demonstrated impressive clinical benefit in some advanced cancers. Nonetheless, in the majority of patients, the successful use of ICIs is limit...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6770350/ https://ncbi.nlm.nih.gov/pubmed/31443339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091223 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|